Nuwellis (NUWE) Operating Margin Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | -2,938.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,938.00 |
| Dec 31, 2025 | 202.00 |
| Sep 30, 2025 | -5,693.00 |
| Jun 30, 2025 | -6,272.00 |
| Mar 31, 2025 | 9,502.00 |
| Dec 31, 2024 | 3,805.00 |
| Sep 30, 2024 | 6,645.00 |
| Jun 30, 2024 | 13,628.00 |
| Mar 31, 2024 | 6,469.00 |
| Dec 31, 2023 | -55,081.00 |
| Sep 30, 2023 | 5,865.00 |
| Jun 30, 2023 | -4,767.00 |
| Mar 31, 2023 | -9,114.00 |
| Dec 31, 2022 | 67,373.00 |
| Sep 30, 2022 | 9,355.00 |
| Jun 30, 2022 | -591.00 |
| Mar 31, 2022 | 4,277.00 |
| Dec 31, 2021 | -72,458.00 |
| Sep 30, 2021 | -5,980.00 |
| Jun 30, 2021 | 2,198.00 |
| Mar 31, 2021 | 813.00 |
| Dec 31, 2020 | 78,605.00 |
| Sep 30, 2020 | 13,640.00 |
| Jun 30, 2020 | 5,363.00 |
| Mar 31, 2020 | 10,870.00 |
| Dec 31, 2019 | -4,152.00 |
| Sep 30, 2019 | -4,817.00 |
| Jun 30, 2019 | 11,621.00 |
| Mar 31, 2019 | 3,098.00 |
| Dec 31, 2018 | 57,572.00 |
| Sep 30, 2018 | -1,265.00 |
| Jun 30, 2018 | -9,102.00 |
| Mar 31, 2018 | -16,371.00 |
| Dec 31, 2017 | -182,607.00 |
| Sep 30, 2017 | 44,890.00 |
| Mar 31, 2015 | -106,271.00 |
| Sep 30, 2014 | 10,847.00 |